These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 18922966

  • 1. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N, Borlak J.
    Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
    [Abstract] [Full Text] [Related]

  • 2. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J, Torok N.
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [Abstract] [Full Text] [Related]

  • 3. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 4. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S, Younossi ZM.
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [Abstract] [Full Text] [Related]

  • 5. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H, Eivindson MV, Hamilton-Dutoit S, Vilstrup H.
    Ugeskr Laeger; 2003 Mar 10; 165(11):1115-8. PubMed ID: 12677985
    [Abstract] [Full Text] [Related]

  • 6. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W, McCullough AJ.
    Semin Gastrointest Dis; 2002 Jan 10; 13(1):17-30. PubMed ID: 11944630
    [Abstract] [Full Text] [Related]

  • 7. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
    Koike K, Moriya K.
    J Gastroenterol; 2005 Apr 10; 40(4):329-36. PubMed ID: 15868369
    [Abstract] [Full Text] [Related]

  • 8. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Apr 10; 103(4):1036-42. PubMed ID: 18177455
    [Abstract] [Full Text] [Related]

  • 9. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL.
    Ned Tijdschr Geneeskd; 2005 Feb 05; 149(6):289-94. PubMed ID: 15730035
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X, Li Z.
    Chin J Dig Dis; 2006 Feb 05; 7(1):7-11. PubMed ID: 16412031
    [Abstract] [Full Text] [Related]

  • 11. Evolving trends in nonalcoholic fatty liver disease.
    Delgado JS.
    Eur J Intern Med; 2008 Mar 05; 19(2):75-82. PubMed ID: 18249301
    [Abstract] [Full Text] [Related]

  • 12. The treatment of NAFLD.
    Trappoliere M, Tuccillo C, Federico A, Di Leva A, Niosi M, D'Alessio C, Capasso R, Coppola F, Dauria M, Loguercio C.
    Eur Rev Med Pharmacol Sci; 2005 Mar 05; 9(5):299-304. PubMed ID: 16231594
    [Abstract] [Full Text] [Related]

  • 13. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
    Wanless IR, Shiota K.
    Semin Liver Dis; 2004 Feb 05; 24(1):99-106. PubMed ID: 15085490
    [Abstract] [Full Text] [Related]

  • 14. Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets.
    George J, Liddle C.
    Mol Pharm; 2008 Feb 05; 5(1):49-59. PubMed ID: 18072723
    [Abstract] [Full Text] [Related]

  • 15. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B, Stremmel W.
    Z Gastroenterol; 2003 Jan 05; 41(1):77-90. PubMed ID: 12541180
    [Abstract] [Full Text] [Related]

  • 16. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC, Berk PD.
    Semin Liver Dis; 2008 Nov 05; 28(4):407-26. PubMed ID: 18956297
    [Abstract] [Full Text] [Related]

  • 17. [Diagnosis and therapy in NASH].
    Tokushige K.
    Rinsho Byori; 2009 Sep 05; 57(9):848-53. PubMed ID: 19860210
    [Abstract] [Full Text] [Related]

  • 18. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N, Younossi ZM.
    Expert Rev Gastroenterol Hepatol; 2008 Apr 05; 2(2):207-15. PubMed ID: 19072356
    [Abstract] [Full Text] [Related]

  • 19. Hepatic microcirculation in fatty liver disease.
    Farrell GC, Teoh NC, McCuskey RS.
    Anat Rec (Hoboken); 2008 Jun 05; 291(6):684-92. PubMed ID: 18484615
    [Abstract] [Full Text] [Related]

  • 20. [Nonalcoholic steatohepatitis--current treatment options].
    Gutkowski K, Gutkowska D, Partyka M.
    Przegl Lek; 2006 Jun 05; 63(2):91-4. PubMed ID: 16967716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.